Agilent Technologies, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.3
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
A
Consensus analyst target of $160.69 is 40% above current price.
⚠ earnings contracting 4% year-over-year.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $160.69 (+40.3%)
16 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
A
PFE
25.3×
Trailing P/E
19.4×
17.4×
Forward P/E
9.4×
18.3%
Profit Margin
12.4%
52.3%
Gross Margin
75.8%
19.9%
ROE
8.9%
7.0%
Revenue Growth
-1.2%
-3.6%
Earnings Growth
—
1.30
Beta
0.39
—
Price / Book
—
$32.4B
Market Cap
$149.8B
$104 – $160
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →